<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001469443</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>08/12/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001979484</issuerCik>
        <issuerName>Above Food Ingredients Inc.</issuerName>
        <issuerCusip>00373V100</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <street1 xmlns="http://www.sec.gov/edgar/common">2305 Victoria Avenue, Suite 001</street1>
          <city xmlns="http://www.sec.gov/edgar/common">Regina, Saskatchewan</city>
          <stateOrCountry xmlns="http://www.sec.gov/edgar/common">Z4</stateOrCountry>
          <zipCode xmlns="http://www.sec.gov/edgar/common">S4P 0S7</zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Arcadia Biosciences, Inc.</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>2738574</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>2738574</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>2738574</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>5.08</classPercent>
      <typeOfReportingPerson>CO</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Above Food Ingredients Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>2305 Victoria Avenue, Suite 001 Regina, Saskatchewan S4P 0S7 Canada</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Arcadia Biosciences, Inc., a Delaware corporation ("Arcadia")</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>5950 Sherry Lane, Suite 215, Dallas, TX 75225</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Delaware</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>2,738,574 shares of common stock</amountBeneficiallyOwned>
        <classPercent>5.08%. The percent of class is based on the sum of (i) 51,191,848 shares of common stock outstanding as of May 2, 2025, as reported by Issuer on its Form 6-K filed with the Securities and Exchange Commission on May 23, 2025, plus (ii) the 2,738,574 shares of common stock owned by Arcadia.</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>2,738,574</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>2,738,574</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Arcadia Biosciences, Inc.</reportingPersonName>
      <signatureDetails>
        <signature>Thomas J. Schaefer</signature>
        <title>Thomas J. Schaefer, CEO</title>
        <date>08/19/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
